Alkeon Capital Management LLC Akero Therapeutics, Inc. Transaction History

Alkeon Capital Management LLC

$58.2 Billion
Q3 2024

A detailed history of Alkeon Capital Management LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 3,325,004 shares of AKRO stock, worth $102 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

3,325,004

Previous 3,327,220 0.07%

Holding current value

$102 Million

Previous $78.1 Million 22.21%

% of portfolio

0.16%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.45 - $29.34 $47,533 - $65,017	-2,216 Reduced 0.07%	3,325,004 $95.4 Million
Q1 2024 May 14, 2024	SELL	$17.76 - $31.18 $7.76 Million - $13.6 Million	-437,000 Reduced 11.61%	3,327,220 $84 Million
Q4 2023 Feb 13, 2024	SELL	$11.38 - $50.33 $35,960 - $159,042	-3,160 Reduced 0.08%	3,764,220 $87.9 Million
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $12.4 Million - $15.7 Million	300,000 Added 8.65%	3,767,380 $191 Million
Q2 2023 Aug 11, 2023	BUY	$36.89 - $56.88 $9.1 Million - $14 Million	246,650 Added 7.66%	3,467,380 $162 Million
Q1 2023 May 12, 2023	SELL	$37.27 - $50.24 $864,104 - $1.16 Million	-23,185 Reduced 0.71%	3,220,730 $123 Million
Q4 2022 Feb 13, 2023	BUY	$33.44 - $54.8 $2.73 Million - $4.47 Million	81,656 Added 2.58%	3,243,915 $178 Million
Q3 2022 Nov 10, 2022	BUY	$10.15 - $34.05 $5.51 Million - $18.5 Million	542,588 Added 20.71%	3,162,259 $108 Million
Q2 2022 Aug 15, 2022	BUY	$8.0 - $15.01 $1.6 Million - $3 Million	200,000 Added 8.27%	2,619,671 $24.8 Million
Q1 2022 May 16, 2022	SELL	$12.97 - $22.26 $778,200 - $1.34 Million	-60,000 Reduced 2.42%	2,419,671 $34.3 Million
Q3 2021 Nov 15, 2021	SELL	$18.65 - $25.46 $186,928 - $255,185	-10,023 Reduced 0.4%	2,479,671 $55.4 Million
Q2 2021 Aug 16, 2021	SELL	$24.81 - $32.35 $150,770 - $196,590	-6,077 Reduced 0.24%	2,489,694 $61.8 Million
Q1 2021 May 17, 2021	BUY	$24.04 - $34.19 $5 Million - $7.12 Million	208,141 Added 9.1%	2,495,771 $72.4 Million
Q4 2020 Feb 16, 2021	BUY	$25.12 - $29.89 $173,905 - $206,928	6,923 Added 0.3%	2,287,630 $59 Million
Q3 2020 Nov 16, 2020	BUY	$30.79 - $39.92 $39.5 Million - $51.2 Million	1,282,333 Added 128.44%	2,280,707 $70.2 Million
Q2 2020 Aug 14, 2020	BUY	$19.25 - $26.76 $1.42 Million - $1.97 Million	73,780 Added 7.98%	998,374 $24.9 Million
Q1 2020 May 15, 2020	BUY	$12.8 - $27.05 $6.21 Million - $13.1 Million	485,000 Added 110.33%	924,594 $19.6 Million
Q4 2019 Feb 14, 2020	SELL	$17.37 - $27.27 $1.1 Million - $1.72 Million	-63,128 Reduced 12.56%	439,594 $9.76 Million
Q3 2019 Nov 14, 2019	BUY	$16.89 - $29.88 $4.76 Million - $8.42 Million	281,722 Added 127.48%	502,722 $11.4 Million
Q2 2019 Aug 14, 2019	BUY	$18.08 - $19.83 $4 Million - $4.38 Million	221,000 New	221,000 $4.23 Million

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.42B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Account

Alkeon Capital Management LLC Akero Therapeutics, Inc. Transaction History